Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
56.0%
% of BBH's 27 holdings also in BBP
26.9%
% of BBP's 55 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
SAREPTA THERAPEUTICS INC | 2.4% | 2.4% | 2.4% |
|
REGENERON PHARMACEUTICALS | 7.9% | 2.0% | 2.0% |
|
MODERNA, INC. | 5.6% | 2.0% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 9.7% | 1.9% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to BBP
|
AMGEN INC | 13.5% |
|
VERTEX PHARMACEUTICALS INC | 7.8% |
|
GILEAD SCIENCES INC | 6.4% |
|
REGENERON PHARMACEUTICALS | 5.9% |
|
IQVIA HOLDINGS INC | 4.9% |
 |
ARGENX SE ADR | 4.4% |
|
ILLUMINA INC | 4.2% |
 |
ICON PLC | 4.2% |
|
MODERNA, INC. | 3.6% |
|
BIOGEN IDEC INC | 2.8% |
BBH Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.6% |
|
AGIOS PHARMACEUTICALS INC | -2.5% |
|
ADMA BIOLOGICS, INC. | -2.5% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
APELLIS PHARMACEUTICALS, INC. | -2.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | -2.1% |